Product Research
Paclitaxel
Docetaxel
Vinorelbine
Ifosfamide
Mesna
Pirarubicin
Aclarubicin
Adriamycin
Daunorubicin
Vincristine
Bleomycin
Lastet



 

Product Research

As an important core in the enterprise management strategy, Main Luck always attaches importance to the new products’ research and development. In order to strengthen the competitive strength in the future market, the company specially established a new drug research and development center with advanced functional equipment, and many of the specialized talents. Through the independent and united mode, "image and innovation combining", depending on the technological advance of domestic and overseas famous drug science research institution, Main Luck Pharmaceuticals Inc. Is devoting to the production development of anticancer medicine and the auxiliary medicine.

With the perfecting and promoting of the treating products which based on the chemical drugs, Main Luck Pharmaceuticals Inc. continuously push forward to the new field of biological pharmaceuticals; devotes to develop high technology content, world leading level anticancer genetic engineering new drug. Meanwhile, develop new preparation field, builds up top technology platform such as sustained release micro-sphere for injection, liposome and colon-specific release updated, to push forward the products update of Chinese medicine industry and technology progress.

"Go out and invite in" is the persistent dealing with our new drug research and development. We welcome powerful science research unit to cooperate with us, and welcome the new and practical research and developing mode; welcome specialized talents to join us. In order to be useful to the cancer patients, wish we would cooperate with each other.

     
     
     
     

 
  国家食品药品监督管理局世界卫生组织中国医学科学院深圳万维医药贸易有限公司  
  深圳万乐药业有限公司 版权所有
Copyright © 2004 Shenzhen Main Luck Phar maceuticals Inc. All right reserved
Email:wanle@wanle.com.cn
 
Home Site Map English Version